A person can maintain normal fasting blood glucose readings for years while silent metabolic dysfunction steadily progresses beneath the surface. It is estimated that only about 7 percent of adults in the United States are metabolically healthy. The vast majority of the population lives in a state of compromised metabolism, placing them at heightened risk for chronic conditions long before an official diagnosis of type 2 diabetes occurs.
Type 2 diabetes develops when the body is repeatedly exposed to more sugar and digestible carbohydrates than it can safely process. Because excessive circulating insulin is cellularly toxic, cells adapt by downregulating their responsiveness to the hormone. To overcome this resistance and clear glucose from the bloodstream, the pancreas secretes progressively larger amounts of insulin. This compensatory cycle creates chronic hyperinsulinemia—a state of elevated circulating insulin that destabilizes the broader endocrine system.
The Cellular Mechanics of Insulin Resistance
When circulating insulin remains chronically high, one of its primary physiological consequences is the absolute inhibition of lipolysis, or fat burning. The body becomes metabolically locked into burning glucose, making progressive weight gain almost inevitable. Exogenous insulin administration in advanced disease states fails to address this root defect; adding more insulin to an already hyperinsulinemic environment simply accelerates metabolic disruption.
Dietary carbohydrates are not the sole stimulus for insulin release. Protein intake also raises insulin levels, as the hormone plays an essential structural role in amino acid transport and protein metabolism. Consequently, replacing refined carbohydrates with large quantities of lean protein does not resolve hyperinsulinemia. Furthermore, elevated insulin directly disrupts immune signaling, leaving the body vulnerable to both overactive inflammatory responses and impaired infection defenses.
What Clinical Follow-Up Data Reveals About Long-Term Risk
The long-term impact of hyperinsulinemia was strikingly illustrated in a 2001 landmark study conducted by researcher Francesco Facchini. The study followed non-diabetic individuals over six years, categorizing them into three groups based on their baseline insulin sensitivity: no insulin resistance, moderate insulin resistance, and severe insulin resistance.
The findings were profound. Over the six-year tracking period, the group with normal insulin sensitivity remained completely free of major chronic disease. The group with moderate insulin resistance began developing essential hypertension, various cancers, and coronary heart disease. The group with severe insulin resistance experienced all of those conditions, along with high rates of type 2 diabetes and stroke.
Crucially, the data demonstrated that type 2 diabetes appeared relatively late in the disease progression. Pathologies like hypertension and common cancers—including breast, prostate, and colorectal cancers—manifested much earlier, at moderate levels of insulin resistance. While obesity is frequently blamed as the primary cause of these conditions, obesity is actually a late-stage symptom of underlying insulin resistance rather than its initial cause.
Hypertension, Salt, and Vascular Stiffness
Hypertension is often the earliest clinical indicator that insulin signaling has broken down. Contrary to conventional advice, dietary salt intake is rarely the primary driver of this elevation. In fact, severe salt restriction has been shown to worsen insulin resistance. Excess circulating insulin prevents the kidneys from properly excreting sodium into the urine, driving fluid retention and peripheral edema.
Simultaneously, hyperinsulinemia stiffens the arterial walls, impairing their natural ability to dilate and contract in response to changing physiological demands. Because vascular tone is sensitive to dietary inputs, blood pressure measurements offer a practical, real-time assessment of metabolic health. When individuals transition away from refined foods, blood pressure readings frequently begin normalizing within as little as two weeks.
Food Processing, Physical Structure, and Seed Oils
The physical form of food plays a critical role in metabolic regulation. Research from the University of Bergen—such as the FATFUNG study—demonstrated that both high-fat diets and unprocessed carbohydrate diets support weight loss and cardiovascular health, provided that refined carbohydrates, added sugars, and industrial omega-6 oils are completely eliminated. When food quality is maintained, macroscopic macronutrient ratios become far less critical.
Processing food through grinding, pulverizing, or juicing fundamentally alters its physiological behavior. Pulverized ingredients stimulate a drastically higher insulin response than whole, intact foods with the exact same carbohydrate content. For instance, drinking a glass of orange juice creates a rapid spike in blood glucose and insulin because the natural fiber matrix has been destroyed. Eating a whole orange delivers the same total carbohydrates but absorbs slowly, avoiding dramatic endocrine spikes that damage the vascular endothelium.
Industrial seed oils rich in linoleic acid—including rapeseed, canola, sunflower, and soybean oils—represent a second major driver of metabolic dysfunction. A 2012 study showed that linoleic acid consumption directly promotes weight gain. When combined with refined sugars, these refined omega-6 fats create a highly inflammatory state. Replacing industrial seed oils with traditional fats like extra virgin olive oil, butter, and natural animal fats eliminates a key driver of insulin resistance.
The systemic damage caused by processed food formulations was illustrated in animal research led by Professor Eric Berg at North Dakota State University. Because swine share a digestive and metabolic physiology nearly identical to humans, pigs were fed a diet formulated strictly according to standard human dietary guidelines. Within three months, the animals suffered severe physiological decline, including brittle bones, halted growth, obesity, and inflammatory skin lesions, requiring the trial to be halted on ethical grounds.
Physical Indicators and Diagnostic Ratios
In addition to cardiovascular disease and type 2 diabetes, insulin resistance is implicated in a vast spectrum of pathologies. These include Alzheimer's disease, non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), gout (driven by fructose conversion into uric acid), Parkinson's disease, sleep apnea, kidney damage, and psychiatric disorders such as depression, bipolar disorder, and schizophrenia.
Physical signs of insulin resistance often appear on the skin and face long before blood tests trigger alarms. Common markers include skin tags (fibromas), acanthosis nigricans (dark, velvety patches of skin in body folds), persistent facial acne, female pattern hair loss, visceral abdominal fat, and swollen ankles. Modern weight-loss pharmaceutical interventions like GLP-1 receptor agonists often cause universal muscle loss along with fat loss, resulting in sagging facial skin (Ozempic face). Conversely, correcting insulin resistance through dietary reform preserves facial muscle tissue while selectively clearing visceral fat.
Evaluating metabolic health can be done using targeted blood calculations. The HOMA-IR formula measures insulin resistance using fasting glucose and fasting insulin: (Fasting Glucose x Fasting Insulin) / 22.5. A score between 0.4 and 1.4 represents normal range, with values of 1.0 or below reflecting optimal insulin sensitivity. Scores above 1.9 indicate early insulin resistance, while values of 2.9 or higher signify severe resistance.
An even simpler assessment is the Triglyceride-to-HDL ratio, calculated by dividing serum triglycerides by HDL cholesterol. A ratio of 1.0 or lower (ideally 0.85 or below) indicates robust insulin sensitivity and the absence of low-grade vascular inflammation. High-carbohydrate diets drive triglycerides up and drop HDL, whereas carbohydrate reduction lowers triglycerides, and natural saturated fats raise HDL.
Systemic Contributors and Practical Next Steps
While diet is the primary lever, several lifestyle and physiological factors accelerate insulin resistance. Chronic psychological stress elevates cortisol, which directly raises blood glucose. Frequent snacking maintains constant insulin exposure throughout the day. Insufficient sleep, physical inactivity, smoking, and deficiencies in key nutrients—including vitamins D, A, and B1, alongside magnesium, potassium, sodium, zinc, and chromium—further impair insulin signaling. Additionally, common medications such as statins, cortisone, diuretics, beta-blockers, and antipsychotics are known to increase insulin resistance.
To evaluate your current metabolic trajectory, review your latest basic lipid panel to calculate your Triglyceride-to-HDL ratio, or request a fasting insulin test alongside fasting glucose from your healthcare provider to calculate your HOMA-IR score.
No comments yet